These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17977612

  • 1. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [Abstract] [Full Text] [Related]

  • 2. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A.
    Antivir Ther; 2009 Jan; 14(5):631-9. PubMed ID: 19704165
    [Abstract] [Full Text] [Related]

  • 3. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
    Bressler BL, Guindi M, Tomlinson G, Heathcote J.
    Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D.
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
    Hanouneh IA, Feldstein AE, Lopez R, Yerian L, Pillai A, Zein CO, Zein NN.
    Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
    [Abstract] [Full Text] [Related]

  • 7. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS, Liu CH, Liu CJ, Wang CC, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH.
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [Abstract] [Full Text] [Related]

  • 8. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, Goulis I, Tzourmakliotis D, Akriviadis E, Manesis EK, Archimandritis AJ.
    Aliment Pharmacol Ther; 2009 Nov 01; 30(9):947-54. PubMed ID: 19604179
    [Abstract] [Full Text] [Related]

  • 9. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2009 Jun 01; 81(6):1032-9. PubMed ID: 19382270
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M, Rebucci C, Cividini A, Pizzolanti G, Minola E, Mondelli MU, Colombo M, Pinzello G, Craxì A.
    Hepatology; 2006 Jan 01; 43(1):64-71. PubMed ID: 16374856
    [Abstract] [Full Text] [Related]

  • 11. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS.
    Liver Int; 2008 Feb 01; 28(2):271-7. PubMed ID: 18028320
    [Abstract] [Full Text] [Related]

  • 12. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y, Mizuta T, Oza N, Takahashi H, Ario K, Yoshimura T, Eguchi Y, Ozaki I, Hisatomi A, Fujimoto K.
    Liver Int; 2009 Jul 01; 29(6):871-7. PubMed ID: 19302179
    [Abstract] [Full Text] [Related]

  • 13. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec 01; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance in chronic hepatitis B virus infection.
    Kumar M, Choudhury A, Manglik N, Hissar S, Rastogi A, Sakhuja P, Sarin SK.
    Am J Gastroenterol; 2009 Jan 01; 104(1):76-82. PubMed ID: 19098853
    [Abstract] [Full Text] [Related]

  • 15. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1349-57. PubMed ID: 17059516
    [Abstract] [Full Text] [Related]

  • 16. [A virological response study of serum leptin level and insulin resistance on the antivirus effect in patients with chronic hepatitis C].
    Zhu B, Zhang P, Wang XH, Sun LH, Jiang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec 01; 14(12):887-9. PubMed ID: 17196129
    [Abstract] [Full Text] [Related]

  • 17. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE.
    J Hepatol; 2008 Mar 01; 48(3):399-406. PubMed ID: 18164507
    [Abstract] [Full Text] [Related]

  • 18. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R, Gelsi E, Giudicelli J, Mariné-Barjoan E, Gual P, Benzaken S, Saint-Paul MC, Sadoul JL, Huet PM, Tran A.
    Eur J Gastroenterol Hepatol; 2007 Aug 01; 19(8):671-7. PubMed ID: 17625437
    [Abstract] [Full Text] [Related]

  • 19. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M, Radu C, Crişan D, Grigorescu MD, Serban A, Neculoiu D, Rusu M, Acalovschi M.
    J Gastrointestin Liver Dis; 2008 Jun 01; 17(2):147-54. PubMed ID: 18568135
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May 01; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.